Peter Marks, the director of the Food and Drug Administration's Center for Biologics Evaluation and Research, said he would resign if the agency pushed out an unproven coronavirus vaccine. The FDA is under immense pressure to release a vaccine, as the number of confirmed coronavirus cases continues to rise, and as President Donald Trump urges health officials to act speedily. "You have to decide where your red line is, and that's my red line," Marks said. Visit Business Insider's homepage for more stories.
A high-level official within the Food and Drug Administration threatened to resign if the agency green-lights an unproven coronavirus vaccine. In a statement to Reuters, Peter Marks, the director of the FDA's Center for Biologics Evaluation and Research, said he "would feel obligated" to step down from his role if the agency approves a dubious vaccine. "In doing so," Marks said, "I would indicate to the American public that there's something wrong." In his role, Marks oversees a team of experts who are responsible for identifying potential coronavirus treatments, the Washington Post reported. Historically, FDA officials like Marks have the final say on medical items issued out to the public. If this trend holds, Marks will be the determining figure on when a vaccine will be released, according to the Post. The FDA did not immediately respond to Business Insider's request for comment. There is mounting pressure to secure a vaccine for the coronavirus, as the number of confirmed cases continues to climb worldwide. More than 5.5 million people have contracted the virus in the United States, according to the latest data compiled by Johns Hopkins University. Of that sum, more than 174,000 Americans have died from it.
President Donald Trump has been urging health officials to work faster to approve a vaccine and said it was possible that one would be available before the November 3 election. Most health experts say it's unlikely that a vaccine could be proven safe that soon. Trump's eagerness to put out a vaccine comes as lawmakers remain critical of him for his response to the coronavirus pandemic. Perhaps more importantly, voters who will take to the polls in November to determine whether he gets re-elected have also indicated they're not satisfied with the way he's handled the pandemic. Only 35% of voters said they approved of his response in a July Quinnipiac University poll. That figure is compared with the overwhelming 62% who said they didn't. Adding on to the pressure, Russia in July announced the release of what President Vladimir Putin has called the first coronavirus vaccine in the world. But the pressure isn't enough to drive officials to put out a vaccine just yet. "You have to decide where your red line is, and that's my red line," Marks said in the statement, adding that he "could not stand by and see something that was unsafe or ineffective that was being put through." Still, scientists and health officials have concerns that the quickly approaching November election will only encourage Trump to double down on the pressure, Reuters reported. The federal government is testing possible treatments, but a vaccine is not likely to be approved before the election, health officials have said. The government hopes to release a proven vaccine by January 2021, Reuters reported, citing Michael Caputo, assistant secretary for public affairs at the Department of Health and Human Services. Join the conversation about this story » NOW WATCH: Epidemiologists debunk 13 coronavirus myths
More like this (3)
© Provided by BGR Coronavirus Vaccine Health officials involved in coronavirus vaccine clinical trials said that...© Provided by BGR Coronavirus Vaccine Health officials involved in coronavirus vaccine clinical trials said that the drugs weren’t designed to stop the spread of COVID-19. The goal was to prevent severe COVID-19 cases and deaths. Preventing infection would be a welcome side effect. That meant vaccinated individuals ...
Summary List PlacementMoncef Slaoui, the head scientist of the federal vaccine initiative Operation Warp Speed, said...Summary List PlacementMoncef Slaoui, the head scientist of the federal vaccine initiative Operation Warp Speed, said on Sunday Moderna's vaccine will likely be approved by next week. In an interview with Fox News Sunday, Slaoui told host Chris Wallace that with approvals behind vaccines from both Pfizer and Moderna, he expected around 40 million vaccine doses to be distributed before the end of 2020....
Summary List PlacementPeople with common allergies to foods or to things in the environment like pollen...Summary List PlacementPeople with common allergies to foods or to things in the environment like pollen or dust probably don't have to worry about having a serious reaction to the just-authorized Pfizer coronavirus vaccine, the US Food and Drug Administration said during a press conference on Saturday. Even people who've had a severe allergic reaction to food or to something in the environment in the...